This post was originally published on this site
https://i-invdn-com.investing.com/news/LYNXNPEC0Q0MJ_M.jpg
The Trade Desk Inc . (NASDAQ:TTD) +16%; reported Q2 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $377 million versus the consensus estimate of $364.87 million.GUIDANCE: The Trade Desk Inc. sees Q3 2022 revenue of at least $385 million, versus the consensus of $382.6 million.
Halozyme Therapeutics (NASDAQ:HALO) +8%; reported Q2 EPS of $0.53, $0.06 better than the analyst estimate of $0.47. Revenue for the quarter came in at $152.4 million versus the consensus estimate of $138.63 million. GUIDANCE: Halozyme Therapeutics sees FY2022 EPS of $2.10-$2.25, versus the consensus of $2.23. Halozyme Therapeutics sees FY2022 revenue of $655-685 million, versus the consensus of $610.9 million.
H&R Block (NYSE:HRB) +4.5%; reported Q2 EPS of $1.43, $0.19 better than the analyst estimate of $1.24. Revenue for the quarter came in at $1.05 billion versus the consensus estimate of $996.33 million. GUIDANCE: H&R Block sees FY2022 EPS of $3.70-$3.95, versus the consensus of $3.46. H&R Block sees FY2022 revenue of $3.535-3.585 billion, versus the consensus of $3.41 billion.
Roblox (RBLX) -13%; reported Q2 EPS of ($0.30), $0.05 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $591.2 million versus the consensus estimate of $639.19 million. Average Daily Active Users (DAUs) were 52.2 million, up 21% year over year
Cano Health (CANO) -8.8%; reported Q2 EPS of ($0.03), $0.01 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $689.4 million versus the consensus estimate of $712.61 million. GUIDANCE: Cano Health sees FY2022 revenue of $2.85-2.9 billion, versus the consensus of $2.86 billion.
Azenta, Inc. (AZTA) -6.3%; reported Q3 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $133 million versus the consensus estimate of $138.73 million.
Coinbase (NASDAQ:COIN) -4%; reported Q2 EPS of ($4.98), may not compare the analyst estimate of ($2.44). Revenue for the quarter came in at $808.3 million versus the consensus estimate of $879.69 million.
